These observations may indicate an association of CTRP9 with obesity-related metabolic dysregulation in diabetic subjects with CKD; however, its functional significance needs to be confirmed in further studies. Here, C1QTNF9 is linked to obesity due to melanocortin 4 receptor deficiency.